New Drugs & Clinical Trial Rules 2019 GCP Compliance Audit Checklist
This checklist covers compliance requirements under New Drugs & Clinical Trial Rules 2019 and applicable Indian regulations for healthcare operations. Non-compliance can result in cancellation of manufacturing licence and penalties up to ₹10 lakh under Section 27 of the Drugs & Cosmetics Act 1940.
- Industry: Healthcare
- Frequency: Quarterly
- Estimated Time: 25-35 minutes
- Role: Clinical Research Manager
- Total Items: 20
- Compliance: New Drugs & Clinical Trial Rules 2019, ICH E6 GCP, CDSCO Guidelines, Schedule Y
CDSCO Licence & GMP Registration
Verify Drugs & Cosmetics Act 1940 manufacturing licence and Schedule M GMP registration.
- Is the manufacturing licence (Form 25 or 28) valid and current for all products manufactured?
- Is a qualified Technical Staff person (B.Pharm or equivalent) appointed and approved by the licencing authority?
- Is the manufacturing site registered with CDSCO for export and does it comply with Schedule M GMP requirements?
- Attach photo of manufacturing licence Form 25/28, Technical Staff appointment, and CDSCO registration:
Premises, Equipment & Utilities Compliance
Verify GMP premises qualification, utilities, and equipment calibration per Schedule M.
- Are all premises, equipment, and utilities qualified per Schedule M GMP and validation master plan?
- Is the water system (Purified Water or WFI) tested per pharmacopoeial limits with records maintained?
- Are all analytical instruments calibrated with valid calibration certificates on file?
- Attach photo of cleanroom qualification, water system test results, and calibration certificates:
Batch Records & OOS Investigation
Verify BMR completeness, OOS investigation compliance, and QA release per Schedule M.
- Is the batch manufacturing record (BMR) complete, reviewed by QA, and available for every batch?
- Is the out-of-specification (OOS) procedure followed and all OOS investigations documented?
- Overall cGMP production and QA compliance status:
- Attach photo of batch manufacturing record, OOS investigation file, and QA release stamp:
CAPA, Complaints & Pharmacovigilance
Verify CAPA system effectiveness and ADR/pharmacovigilance compliance per CDSCO requirements.
- Is the CAPA system effectively identifying, investigating, and preventing recurrence of quality issues?
- Are product complaints investigated and Adverse Drug Reactions (ADRs) reported to CDSCO PvPI portal?
- Number of open CAPAs beyond target closure date:
- Quality Director or Head of Quality certification:
Corrective Actions & Inspector Sign-Off
Document all deficiencies and assign corrective actions. POPProbe auto-assigns these to team members, generates a signed PDF report instantly, and tracks compliance status across all locations. -> Start free, no credit card required
- List all deficiencies identified in this inspection:
- Overall compliance status?
- Corrective actions assigned to (name and department):
- Inspector digital signature and date:
Related Health Services Checklists
- ISO 13485:2016 & Medical Devices Rules 2017 India QMS Audit
- New Drugs & Clinical Trials Rules 2019 Clinical Site GCP Inspection
- Drugs & Cosmetics Act Blood Bank Annual Licence Renewal Audit
- Medical Devices Rules 2017 Post-Market Surveillance Plan Audit
- BMW Management Rules 2016 Healthcare Biomedical Waste Compliance
- NABH Hospital Accreditation Standards 5th Edition Compliance Audit
- NABH Standards HIC Infection Prevention & Control Audit Checklist
- NABH Standards MM Medication Management Safety Audit Checklist
Related Pharmaceutical Checklists
- Medical Devices Rules 2017 Schedule 3 QMS Audit Checklist - FREE Download
- ISO 13485:2016 & Medical Devices Rules 2017 India QMS Audit - FREE Download
- New Drugs & Clinical Trials Rules 2019 Clinical Site GCP Inspection - FREE Download
- Drugs & Cosmetics Act Blood Bank Annual Licence Renewal Audit - FREE Download
- Medical Devices Rules 2017 Post-Market Surveillance Plan Audit - FREE Download
- Clinical Establishments Act 2010 Hospital Pharmacy Compliance Audit - FREE Download
- Drugs & Cosmetics Rules Schedule H1 High-Risk Drug Sales Compliance - FREE Download
- AERB & BARC Radiopharmacy Nuclear Medicine Safety Compliance Audit - FREE Download
- CDSCO Combination Products Drug-Device Regulatory Compliance Audit - FREE Download
- CDSCO CTD Module 4 Non-Clinical Study Reports Compliance Audit - FREE Download
Why Use This New Drugs & Clinical Trial Rules 2019 GCP Compliance Audit Checklist?
This new drugs & clinical trial rules 2019 gcp compliance audit checklist helps healthcare teams maintain compliance and operational excellence. Designed for clinical research manager professionals, this checklist covers 20 critical inspection points across 5 sections. Recommended frequency: quarterly.
Ensures compliance with New Drugs & Clinical Trial Rules 2019, ICH E6 GCP, CDSCO Guidelines, Schedule Y. Regulatory-aligned for audit readiness and inspection documentation.
Frequently Asked Questions
What is a New Drugs & Clinical Trial Rules 2019 GCP Compliance Audit Checklist?
A New Drugs & Clinical Trial Rules 2019 GCP Compliance Audit Checklist is a standardized inspection form used by clinical research manager to ensure consistent healthcare operations. It contains 27 inspection points organized into 5 sections. FREE PDF - New Drugs & Clinical Trial Rules 2019 GCP Compliance compliance checklist for Indian operations. Covers New Drugs & Clinical Trial Rules 2019 requirements. Download FREE template.
How often should I use this healthcare checklist?
This checklist is designed to be completed quarterly. Regular use ensures compliance with New Drugs & Clinical Trial Rules 2019 and ICH E6 GCP and helps identify issues before they become problems.
Can I download this New Drugs & Clinical Trial Rules 2019 GCP Compliance Audit Checklist as a PDF?
Yes, you can download this checklist as a FREE PDF for printing or offline use. The checklist includes 27 fields across 5 sections and typically takes 25-35 minutes to complete.
What compliance standards does this checklist cover?
This checklist helps ensure compliance with New Drugs & Clinical Trial Rules 2019, ICH E6 GCP, CDSCO Guidelines, Schedule Y. Following these standards protects your organization and ensures best practices.
How do I complete this healthcare inspection checklist?
Begin by completing the header fields for Facility / Unit Name, Inspection Date, Inspector Name & Designation, and Factory/Registration Number. Work through each of the 5 sections, marking items Yes or No as applicable. Add notes for any issues found. Finally, complete the footer fields and add your signature. The entire process takes approximately 25 to 35 minutes.
What are the key sections in this healthcare checklist?
This healthcare checklist is organized into 5 key sections: CDSCO Licence & GMP Registration, Premises, Equipment & Utilities Compliance, Batch Records & OOS Investigation, CAPA, Complaints & Pharmacovigilance, Corrective Actions & Inspector Sign-Off. Each section contains specific inspection points that clinical research manager must verify. The structured layout ensures nothing is missed during healthcare inspections and makes the process efficient, typically taking 25-35 minutes to complete.
Who should use this New Drugs & Clinical Trial Rules 2019 GCP Compliance Audit Checklist?
This checklist is primarily designed for clinical research manager working in healthcare operations. However, it is also valuable for quality assurance teams, safety officers, compliance managers, and supervisors who need to verify that healthcare standards are being met. Organizations of all sizes can benefit from using this New Drugs & Clinical Trial Rules 2019 GCP Compliance Audit Checklist to maintain consistency and accountability.